The most important are Smads 2 and 3, which control TGF-β in renal fibrosis, being fibroblasts highly activated in DN, hypertensive nephropathy, and obstructive kidney disease [58,59,60]. This evidence concerns the gene TGFB1 and renal fibrosis.